No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
NAVB Navidea Biopharmaceuticals
- 0.000
- 0.0000.00%
15min DelayClose Dec 24 13:00 ET
10.01KMarket Cap0.00P/E (TTM)
0.000High0.000Low11.95KVolume0.000Open0.000Pre Close1.20Turnover0.02%Turnover Ratio0.00P/E (Static)100.08MShares0.13052wk High0.00P/B6.78KFloat Cap0.00052wk Low--Dividend TTM67.83MShs Float365.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024
Navidea Biopharmaceuticals, Inc. Announces Special Meeting of Stockholders to Be Held July 8, 2024
Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend Its SEC Reporting Obligations
Navidea Settles Litigation With Capital Royalty, Stock Rallies 30%
Navidea Biopharmaceuticals, CRG Settle All Ongoing Litigation
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
Heat List
US
Overall
Symbol
Price
% Chg
No Data